Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

被引：12
|
作者：
Russano, Marco [1 ]
La Cava, Giulia [1 ]
Cortellini, Alessio [1 ]
Citarella, Fabrizio [1 ]
Galletti, Alessandro [2 ]
Di Fazio, Giuseppina Rita [1 ]
Santo, Valentina [1 ]
Brunetti, Leonardo [1 ]
Vendittelli, Alessia [1 ]
Fioroni, Iacopo [1 ]
Pantano, Francesco [1 ]
Tonini, Giuseppe [1 ]
Vincenzi, Bruno [1 ]
机构：
[1] Campus Biomed Univ Rome, Dept Med Oncol, Via Alvaro Portillo 21, I-00128 Rome, Italy
[2] San Camillo Forlanini Hosp, Div Med Oncol, I-00152 Rome, Italy
来源：
CURRENT ONCOLOGY | 2023年 / 30卷 / 02期
关键词：
immunotherapy; non-small cell lung cancer; immune checkpoint inhibitors; PD-1; PD-L1; antibodies; combination strategies; biomarkers; tissue biomarkers; liquid biopsy; IMMUNE CHECKPOINT INHIBITORS; PD-L1; EXPRESSION; NSCLC PATIENTS; OPEN-LABEL; CHEMOTHERAPY CHEMO; 1ST-LINE NIVOLUMAB; ADVERSE EVENTS; CHECKMATE; 9LA; PATIENTS PTS; PHASE-III;
D O I：
10.3390/curroncol30020181
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunotherapy has revolutionized the treatment paradigm of non-small cell lung cancer and improved patients' prognosis. Immune checkpoint inhibitors have quickly become standard frontline treatment for metastatic non-oncogene addicted disease, either as a single agent or in combination strategies. However, only a few patients have long-term benefits, and most of them do not respond or develop progressive disease during treatment. Thus, the identification of reliable predictive and prognostic biomarkers remains crucial for patient selection and guiding therapeutic choices. In this review, we provide an overview of the current strategies, highlighting the main clinical challenges and novel potential biomarkers.
引用
收藏
页码：2366 / 2387
页数：22
相关论文
共 50 条
  • [31] Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
    Ge, Yang
    Ye, Ting
    Fu, Siyun
    Jiang, Xiaoying
    Song, Hang
    Liu, Bin
    Wang, Guoquan
    Wang, Jinghui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Study on Biomarkers for Predictive the Clinical Efficacy of Non-small Cell Lung Cancer Immunotherapy
    Cui, T.
    Tian, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S613 - S613
  • [33] Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Biomarkers Associated with Early Death
    Munoz Del Toro, Jacobo
    Olmedo, Eugenia
    Gomez, Ana
    Madariaga, Ainhoa
    Perez Templado, Josefa
    Gorospe, Luis
    Reguera, Pablo
    Soria, Ainara
    Gion, Maria
    Martinez, Olga
    Molina, Javier
    Villamayor, Maria
    Saavedra, Cristina
    Munoz, Gema
    Albarran, Victor
    Benito, Amparo
    Barquin, Arantzazu
    Cabanero, Alberto
    Alonso, Teresa
    Gajate, Pablo
    Grande, Enrique
    Garrido, Pilar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1325 - S1326
  • [34] Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Wu, Xinyu
    Chau, Yi Fung
    Bai, Hua
    Zhuang, Xiaofei
    Wang, Jie
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [35] Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer
    Wang, Yunzhen
    Huang, Sha
    Feng, Xiangwei
    Xu, Wangjue
    Luo, Raojun
    Zhu, Ziyi
    Zeng, Qingxin
    He, Zhengfu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives
    Luo, Wenxin
    Wang, Zhoufeng
    Zhang, Ting
    Yang, Lan
    Xian, Jinghong
    Li, Yalun
    Li, Weimin
    PRECISION CLINICAL MEDICINE, 2021, 4 (04) : 258 - 270
  • [37] Update From ASCO: Advances in Immunotherapy for Non-Small Cell Lung Cancer and Melanoma
    Schwarzberg, Abraham
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (03) : 22 - 28
  • [38] Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy era
    Zhang, David
    Rohatgi, Anjali
    CANCER, 2025, 131 (01)
  • [39] Characterization of the Entire Metastatic Spectrum for Non-Small Cell Lung Cancer in the Immunotherapy Era
    Andraos, T. Y.
    Shirvani, S.
    Cornwell, T.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E428 - E429
  • [40] First-line combination immunotherapy for metastatic non-small cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 433 - 441
12345